Lamotrigine Extended-Release 200 mg/1
lamotrigine · TABLET, FILM COATED, EXTENDED RELEASE · Par Health USA, LLC
No Recall HistoryCurrently in Shortage
Plain English
Lamotrigine Extended-Release is a tablet, film coated, extended release containing lamotrigine at 200 mg/1, taken oral. Manufactured by Par Health USA, LLC.
Key Facts
- Brand Name
- Lamotrigine Extended-Release
- Generic Name
- lamotrigine
- NDC Code (Product)
10370-208- Manufacturer
- Par Health USA, LLC
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA201374
- Drug Class
- Anti-epileptic Agent [EPC]; Mood Stabilizer [EPC]
- Marketing Start
- 01/02/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Lamotrigine Extended-Release used for?
Lamotrigine Extended-Release contains lamotrigine. It is a tablet, film coated, extended release taken oral. Consult your doctor for specific uses.
Is Lamotrigine Extended-Release a controlled substance?
Lamotrigine Extended-Release is not classified as a controlled substance by the DEA.
What is the generic name for Lamotrigine Extended-Release?
The generic name for Lamotrigine Extended-Release is lamotrigine. There are 11 other brand versions of lamotrigine.
What is the NDC code for Lamotrigine Extended-Release 200 mg/1?
The NDC (National Drug Code) for Lamotrigine Extended-Release 200 mg/1 is 10370-208, listed by Par Health USA, LLC.